Recap: Collegium Pharmaceutical Q3 Earnings - Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical COLL reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Collegium Pharmaceutical beat estimated earnings by 157.69%, reporting an EPS of $1.34 versus an estimate of $0.52.

Revenue was up $9.70 million from the same period last year.

Last quarter the company beat on EPS by $0.04 which was followed by a 6.68% increase in the share price the next day.

Here's a look at Collegium Pharmaceutical's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	1.22	0.31	-0.14	-0.13
EPS Actual	1.26	1.32	1.09	1.10
Revenue Estimate	137.98M	138.47M	125.19M	124.45M
Revenue Actual	135.55M	144.77M	129.62M	127.01M

To track all earnings releases for Collegium Pharmaceutical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.